December 2025 ZOHU/Call Webinar

What to know

  • A video recording of this webinar is posted below. Visit CDC TRAIN to get free continuing education (CE) for this webinar.

1 hour

Dec 10, 2025

Webinar details

Presentation topics

  • Close genetic relatedness of carbapenem-resistant Enterobacterales from companion animals and humans
  • Veterinary Infection Prevention and Control (IPC) in Companion Animal Settings, and a New Firstline Tool for Veterinary IPC Guidance
  • Association for Professionals in Infection Control and Epidemiology (APIC) Veterinary Medicine Infection Prevention and Control (IPC) Council: Advancing Veterinary IPC Through Collaboration and Standardization

Featuring

Allison James, DVM, MPH, PhD | Presenter
Lead, One Health Antimicrobial Resistance Program
Centers for Disease Control and Prevention
Karen Alroy, DVM MPH DACVPM | Presenter
Medical Epidemiologist
One Health Lead Antimicrobial Resistance Unit, New York City Department of Health and Mental Hygiene
Leslie Kollman, BS, AAS, CVT, CIC | Presenter
Veterinary Infection Preventionists
Minnesota Department of Health

Continuing Education (CE)

Visit CDC Train to receive continuing education (CE).

Web-on-Demand (Recording)

  • Course Name: WD4565R -121025
  • Start Date: January 15, 2026
  • End Date: January 13, 2028

Series objectives

1. Identify an implication for human, animal, and environmental health.

2. Identify a One Health approach strategy for prevention of public health threats.

3. Identify a One Health approach strategy for detection of public health threats.

4. Identify a One Health approach strategy for responding to public health threats.

5. List two ways to improve collaborative practice across the public healthcare team.

Disclosures

In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial or in-kind support for this activity.